NCT01717222View on ClinicalTrials.gov

Effect of Intraperitoneal and Intravenous Lignocaine on Pain Relief Following Laparoscopic Cholecystectomy

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions
Pain, PostoperativeAnalgesic RequirementStress ResponseReturn of Bowel ActivityInadequate or Impaired Respiratory Function
Interventions
DRUG

Intraperitoneal Lignocaine

Patients will receive 100 ml of 0.2% lignocaine

DRUG

Intravenous Lignocaine

Intravenous group patients will receive 1.5mg/kg of lignocaine as bolus dose at induction and 2mg/kg/hour as continuous infusion until one hour after surgery

Trial Locations (1)

605006

Department of Surgery, JIPMER, Puducherry

All Listed Sponsors
lead

Jawaharlal Institute of Postgraduate Medical Education & Research

OTHER_GOV

NCT01717222 - Effect of Intraperitoneal and Intravenous Lignocaine on Pain Relief Following Laparoscopic Cholecystectomy | Biotech Hunter | Biotech Hunter